Derma Sciences, Inc. Common Stock (DE)
DSCI
DSCI was delisted on the 23rd of February, 2017.
62 hedge funds and large institutions have $172M invested in Derma Sciences, Inc. Common Stock (DE) in 2015 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 19 reducing their positions, and 18 closing their positions.
26% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 19
4% less capital invested
Capital invested by funds: $180M → $172M (-$7.93M)
6% less funds holding
Funds holding: 66 → 62 (-4)
22% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 18
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $15K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.03M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$2.16M |
| 3 |
Millennium Management
New York
|
+$2.04M |
| 4 |
Renaissance Technologies
New York
|
+$1.81M |
| 5 |
Goldman Sachs
New York
|
+$1.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$7.57M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$5.25M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$4.22M |
| 4 |
O
OrbiMed
New York
|
-$2.54M |
| 5 |
JP Morgan Chase
New York
|
-$1.9M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RFC
76
Russell Frank Company
Seattle,
Washington
| – | -$20K | -2,312 | Closed |
|
77
AllianceBernstein
Nashville,
Tennessee
| – | -$8K | -1,000 | Closed |
|
78
BlackRock
New York
| – | -$5K | -596 | Closed |
|
79
BNP Paribas Financial Markets
Paris,
France
| – | -$4.36K | -515 | Closed |
|
80
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1K | -69 | Closed |
|
DSCI Hedge Fund Activity: Q2 2015 in Review
62 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences, Inc. Common Stock (DE) (DSCI) for Q2 2015, worth a combined $172M — down 4.4% from $180M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of DSCI and 14 opened new positions — a net loss of 4 holders — while 19 trimmed existing stakes and 24 added.
The largest buyer was Fidelity Investments, adding an estimated $4.03M. The largest seller was HealthCor Management, exiting entirely with an estimated $7.57M sold.
- 62 institutional investors held Derma Sciences, Inc. Common Stock (DE) (DSCI) as of Q2 2015, down from 66 in Q1 2015.
- Funds reported $172M of Derma Sciences, Inc. Common Stock (DE) stock for Q2 2015, down 4.4% quarter-over-quarter.
- 14 funds opened new Derma Sciences, Inc. Common Stock (DE) positions in Q2 2015 and 18 closed out, a net change of -4 holders.
- The largest Derma Sciences, Inc. Common Stock (DE) buyer in Q2 2015 was Fidelity Investments, an estimated $4.03M added.
- The largest Derma Sciences, Inc. Common Stock (DE) seller in Q2 2015 was HealthCor Management, an estimated $7.57M sold.
Based on aggregated 13F filings for Q2 2015.